Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty

Inclusion Criteria:

1. Subjects voluntarily participate in the trial and sign the informed consent form;

2. Aged 18 to 80 years old (inclusive), regardless of gender;

3. Patients who need total knee replacement surgery;

4. Those who can communicate well with the researchers and comply with the trialrequirements.

Exclusion Criteria:

1. Patients who are allergic to the drugs used in this trial or the implant materials;

2. Patients with immature bone development;

3. Patients with active infection;

4. Patients with neuropathy of the knee joint;

5. Patients with poor bone quality that is not conducive to prosthesis fixation;

6. Patients with general conditions or concomitant diseases that make it difficult forpeople to tolerate surgery;

7. Patients with insufficient quadriceps muscle strength;

8. Patients with insufficient skin coverage near the surgical site and intolerance tosurgery;

9. Patients with severe femoral or tibial deformities and other severe deformitiesoutside the joint;

10. Patients with metal implants in the joint surgical area that affect the execution ofthe surgical plan;

11. Pregnant or lactating women;

12. Patients with severe epilepsy or mental illness;

13. Patients with alcohol dependence or drug addiction;

14. Patients with severe coagulation disorders;

15. Patients who have participated in or are participating in other clinical trialswithin one month of enrollment;

16. Patients who are considered by the researchers to be unsuitable for participating inthis clinical trial for other reasons. Those who meet any of the above exclusioncriteria need to be excluded.